Pharma Focus Europe


The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Volastra Therapeutics Commences First Patient Treatment in Phase I/II Clinical Study of VLS-1488, Part of Their Unique Range of KIF18A Inhibitors

Tuesday, October 31, 2023

Volastra Therapeutics a biotechnology company specializing in cancer research has announced the commencement of the first patients dosing in a Phase III clinical trial evaluating VLS VLS in combination

SparX Biopharmaceutical Granted FDA Authorization for IND Submission of SPX-303, an Innovative Anti-LILRB2/PD-L1 Antibody Medication for Human Trials

Tuesday, October 31, 2023

SparX Biopharmaceutical Corp has achieved a significant milestone in the field of powered antibody therapies with the approval of its Investigational New Drug application for SPX by the US Food and Drug Administration

Merck KGaA, Darmstadt, Germany, Strengthens Oncology Pipeline with Hengrui Partnership

Monday, October 30, 2023

Merck KGaA Darmstadt Germany a prominent science and technology company has announced a strategic partnership with Jiangsu Hengrui Pharmaceuticals Co Ltd This collaboration involves an exclusive global

First Clinical Results of ATA-100, a Gene Therapy for Treating Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), Shared at ESGCT

Saturday, October 28, 2023

Atamyo Therapeutics a biotechnology company dedicated to advancing newgeneration gene therapies for the treatment of muscular dystrophies and cardiomyopathies has today unveiled the initial clinical

IDP Pharma Commences Phase 1/2 Clinical Trial for IDP-121, a Novel Direct cMyc Protein Inhibitor and Degrader

Friday, October 27, 2023

IDP Pharma a clinicalstage biotechnology company is pioneering the development of drugs that directly target and degrade intrinsically disordered proteins IDPs They have announced the successful dosing

AGC Biologics and Medigene Collaborate on TCR-T Cell Services Agreement to Advance New Cell Therapy Products

Thursday, October 26, 2023

AGC Biologics a prominent biopharmaceutical development and contract manufacturing organization has recently entered into a new service agreement with Medigene

TC BioPharm Partners with Excellos as CDMO to Meet Expanding US Clinical Trial Demands

Thursday, October 26, 2023

TC BioPharm has revealed its partnership with Excellos a Contract Development Manufacturing Organization based in San Diego California Excellos which originated from the San Diego Blood Bank

The FDA Grants Approval for a Novel Therapy Targeting Rare Blood Cancers Known as Myelodysplastic Syndromes

Wednesday, October 25, 2023

Today the US Food and Drug Administration has granted its approval to Tibsovo for the treatment of adult patients with relapsed or refractory RR myelodysplastic syndromes who carry an isocitrate dehydrogenase

Endogena Therapeutics Receives FDA Authorization for Innovative Treatment Targeting AMD

Wednesday, October 25, 2023

Endogena Therapeutics Inc a pioneering biotechnology company dedicated to advancing regenerative medicine is excited to announce a significant achievement with the potential to transform lives The US Food and Drug Administration

Genialis and Cancer Research Horizons Collaborate to Develop AI-Enhanced Patient Classification Tools for Cancer Research

Tuesday, October 24, 2023

Genialis a company specializing in RNAbased biomarkers has announced a collaborative datasharing initiative with Cancer Research Horizons the innovation division of Cancer Research UK